BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 18298907)

  • 1. Intracoronary adenosine improves myocardial perfusion in late reperfused myocardial infarction.
    Tian F; Chen YD; Lü SZ; Song XT; Yuan F; Fang F; Li ZA
    Chin Med J (Engl); 2008 Feb; 121(3):195-9. PubMed ID: 18298907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of intracoronary administration of anisodamine on slow reflow phenomenon following primary percutaneous coronary intervention in patients with acute myocardial infarction.
    Fu XH; Fan WZ; Gu XS; Wei YY; Jiang YF; Wu WL; Li SQ; Hao GZ; Wei QM; Xue L
    Chin Med J (Engl); 2007 Jul; 120(14):1226-31. PubMed ID: 17697572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".
    Bruder O; Breuckmann F; Jensen C; Jochims M; Naber CK; Barkhausen J; Erbel R; Sabin GV;
    Herz; 2008 Mar; 33(2):136-42. PubMed ID: 18344033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Shen J; Zhang Q; Zhang RY; Zhang JS; Hu J; Yang ZK; Zheng AF; Zhang X; Shen WF
    Coron Artery Dis; 2008 Jun; 19(4):271-7. PubMed ID: 18480672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three hours continuous injection of adenosine improved left ventricular function and infarct size in patients with ST-segment elevation myocardial infarction.
    Zhang H; Tian NL; Hu ZY; Wang F; Chen L; Zhang YJ; Chen SL
    Chin Med J (Engl); 2012 May; 125(10):1713-9. PubMed ID: 22800889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute Myocardial Infarction with Hyperoxemic Therapy (AMIHOT): a prospective, randomized trial of intracoronary hyperoxemic reperfusion after percutaneous coronary intervention.
    O'Neill WW; Martin JL; Dixon SR; Bartorelli AL; Trabattoni D; Oemrawsingh PV; Atsma DE; Chang M; Marquardt W; Oh JK; Krucoff MW; Gibbons RJ; Spears JR;
    J Am Coll Cardiol; 2007 Jul; 50(5):397-405. PubMed ID: 17662390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Administration of intracoronary bone marrow mononuclear cells on chronic myocardial infarction improves diastolic function.
    Yao K; Huang R; Qian J; Cui J; Ge L; Li Y; Zhang F; Shi H; Huang D; Zhang S; Sun A; Zou Y; Ge J
    Heart; 2008 Sep; 94(9):1147-53. PubMed ID: 18381377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prediction of 2-year outcome by combining TIMI myocardial perfusion grading with sum ST segment resolution in patients with acute myocardial infarction].
    She F; Zhang FC; Wei FJ; Mao JM; Guo LJ; Li HY; Niu J; Feng XH; Zhao YM; Lü JQ; Guo JX; Gao W
    Zhonghua Yi Xue Za Zhi; 2005 Oct; 85(40):2835-7. PubMed ID: 16324341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous versus intracoronary myocardial contrast echocardiography for evaluation of no-reflow after primary percutaneous coronary intervention.
    Song JM; Lee JH; Kim YH; Kang DH; Song JK; Hong MK; Park SW; Park SJ; Kim YH
    Echocardiography; 2005 Nov; 22(10):818-25. PubMed ID: 16343164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracoronary streptokinase after primary percutaneous coronary intervention.
    Sezer M; Oflaz H; Gören T; Okçular I; Umman B; Nişanci Y; Bilge AK; Sanli Y; Meriç M; Umman S
    N Engl J Med; 2007 May; 356(18):1823-34. PubMed ID: 17476008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effect of adenosine on myocardial perfusion in patients treated with primary percutaneous coronary intervention for acute myocardial infarction.
    Wang J; Chen YD; Zhi G; Xu Y; Chen L; Liu HB; Zhou X; Tian F
    Clin Exp Pharmacol Physiol; 2012 Mar; 39(3):247-52. PubMed ID: 22214231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracoronary nitroprusside in the prevention of the no-reflow phenomenon in acute myocardial infarction.
    Pan W; Wang LF; Yu JH; Fan Y; Yang SS; Zhou LJ; Li Y; Li WM
    Chin Med J (Engl); 2009 Nov; 122(22):2718-23. PubMed ID: 19951602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Beneficial effects of diltiazem on myocardial no-reflow in a mini-swine model of acute myocardial infarction and reperfusion].
    Zhao JL; Yang YJ; You SJ; Jing ZC; Wu YJ; Yang WX; Meng L; Tian Y; Chen JL; Gao RL; Chen ZJ
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(10):679-83. PubMed ID: 15932731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long term follow-up on emergent intracoronary autologous bone marrow mononuclear cell transplantation for acute inferior-wall myocardial infarction].
    Huang RC; Yao K; Zou YZ; Ge L; Qian JY; Yang J; Yang S; Niu YH; Li YL; Zhang YQ; Zhang F; Xu SK; Zhang SH; Sun AJ; Ge JB
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(16):1107-10. PubMed ID: 16796836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of microvascular reperfusion on prognosis and left ventricular function in anterior wall myocardial infarction treated with primary angioplasty.
    Araszkiewicz A; Lesiak M; Grajek S; Prech M; Grygier M; Mularek-Kubzdela T; Cieslinski A
    Int J Cardiol; 2007 Jan; 114(2):183-7. PubMed ID: 16793152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of cardiac function after transplantation of autologous bone marrow mesenchymal stem cells in patients with acute myocardial infarction.
    Chen SL; Fang WW; Qian J; Ye F; Liu YH; Shan SJ; Zhang JJ; Lin S; Liao LM; Zhao RC
    Chin Med J (Engl); 2004 Oct; 117(10):1443-8. PubMed ID: 15498362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of percutaneous coronary intervention for infarct-related artery only or for both infarct- and non-infarct-related arteries in patients with ST-elevation myocardial infarction and multi-vessel disease.
    Han YL; Wang B; Wang XZ; Li Y; Wang SL; Jing QM; Wang G; Ma YY; Luan B
    Chin Med J (Engl); 2008 Dec; 121(23):2384-7. PubMed ID: 19102953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased no-reflow in patients with anterior myocardial infarction and pre-infarction angina.
    Karila-Cohen D; Czitrom D; Brochet E; Faraggi M; Seknadji P; Himbert D; Juliard JM; Assayag P; Steg PG
    Eur Heart J; 1999 Dec; 20(23):1724-30. PubMed ID: 10562480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Open-label, randomized, placebo-controlled evaluation of intracoronary adenosine or nitroprusside after thrombus aspiration during primary percutaneous coronary intervention for the prevention of microvascular obstruction in acute myocardial infarction: the REOPEN-AMI study (Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction).
    Niccoli G; Rigattieri S; De Vita MR; Valgimigli M; Corvo P; Fabbiocchi F; Romagnoli E; De Caterina AR; La Torre G; Lo Schiavo P; Tarantino F; Ferrari R; Tomai F; Olivares P; Cosentino N; D'Amario D; Leone AM; Porto I; Burzotta F; Trani C; Crea F
    JACC Cardiovasc Interv; 2013 Jun; 6(6):580-9. PubMed ID: 23683738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized evaluation of intracoronary nitroprusside vs. adenosine after thrombus aspiration during primary percutaneous coronary intervention for the prevention of no-reflow in acute myocardial infarction: the REOPEN-AMI study protocol.
    Niccoli G; D'amario D; Spaziani C; Cosentino N; Marino M; Rigattieri S; Schiavo PL; De Vita MR; Tarantino F; Bartorelli A; Fabbiocchi F; Prati F; Imola F; Valgimigli M; Ferrari R; Crea F
    J Cardiovasc Med (Hagerstown); 2009 Jul; 10(7):585-92. PubMed ID: 19384242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.